FRESH-PEF60097-en
Follow-up of a cohort of patients who received umbilical cord blood transplantation with malignant and non-malignant haematological diseases
EUROCORD
| Name | Country code |
|---|---|
| United kingdom | gb |
| Sweden | se |
| Norway | no |
| Germany | de |
| Italy | it |
| Spain | es |
| France | fr |
| Belgium | be |
| Congo | cg |
| Iceland | is |
| Denmark | dk |
['Participant-reported health data']
Individuals
| Topic | Vocabulary |
|---|---|
| Cardiology and vascular medicine | health theme |
| Hematology | health theme |
| Malignant haematopoietic neoplasms without further specification | cim-11 |
| Healthcare system determinants: Use of care | health determinant |
| Healthcare system determinants | health determinant |
{"level_sex_clusion_I":[{"value":"Male","concept":{"vocab":"MeSH","vocabURI":"D008297"}},{"value":"Female","concept":{"vocab":"MeSH","vocabURI":"D005260"}}],"level_age_clusion_I":[{"value":"Young Adult (19 to 24 years)","concept":{"vocab":"MeSH","vocabURI":"D055815"}},{"value":"Adult (25 to 44 years)","concept":{"vocab":"MeSH","vocabURI":"D000328"}},{"value":"Middle Aged (45 to 64 years)","concept":{"vocab":"MeSH","vocabURI":"D008875"}}],"level_type_clusion_I":"Patients population","level_type_clusion_other":"","clusion_I":"All patients who received one or two units of umbilical cord blood in Europe or international patients who received one or two units of cord blood from European banks","clusion_E":""}
| Name |
|---|
| Vanderson;ROCHA |
| Name | Role |
|---|---|
| UNIVERSITE PARIS CITE | sponsor |
| Name |
|---|
| AGENCE DE LA BIOMEDECINE |
| ASSISTANCE PUBLIQUE HOPITAUX DE PARIS (AP-HP) |
| Agency name |
|---|
| CNIL |
['Through organizations (health services or institutions, schools, businesses, etc.)']
['{"concept":{"vocabURI":"Other","vocab":"CESSDA"},"value":"Other"}']
Access on specific project only
Observational Study
| Start | End |
|---|---|
| 1998-01-01 | 3000-01-01 |
Access determined by the Eurocord Scientific Council, The French Stem Cell Society (sfgm-tc) and EBMT.Contractual access with Biotech and pharmaceutical industry in discussion, but not currently active
{"value":"Restricted access","extLink":[{"title":"COAR","uri":"http://purl.org/coar/access_right/c_16ec"}]}
Data may be used by academic teams . To be defined if data may be used by industrial teams.
| Name | |
|---|---|
| Vanderson;ROCHA | rocha.vanderson@hotmail.fr |